Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia

2025年 1月 17日

Read More

Zai Lab Announces Positive Topline Results for TIVDAK in the China Subpopulation of the Global Phase 3 innovaTV 301 Trial in Patients with Recurrent or Metastatic Cervical Cancer

2025年 1月 15日

Read More

Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate

2025年 1月 09日

Read More